# Low-Dose Dexamethasone Suppression Test ## Quick Answer - The low-dose dexamethasone suppression test (LDDST) is a core diagnostic tool veterinarians use to differentiate pituitary-dependent hyperadrenocorticism from adrenal tumors in dogs with suspected Cushing syndrome. - Perform the test by collecting baseline cortisol, administering a low dexamethasone dose intravenously, then collecting post-dexamethasone cortisol samples at 4 and 8 hours, with interpretation based on cortisol suppression patterns. - The LDDST requires strict protocol adherence because stress, concurrent illness, and certain medications can produce false positives or negatives, so borderline results warrant additional testing such as the ACTH stimulation test or abdominal ultrasound. ## Understanding the Low-Dose Dexamethasone Suppression Test The low-dose dexamethasone suppression test is a dynamic endocrine function test used in veterinary medicine to evaluate the hypothalamic-pituitary-adrenal (HPA) axis in dogs. The test relies on the principle that dexamethasone, a synthetic glucocorticoid, suppresses cortisol secretion in healthy animals through negative feedback on the pituitary gland. In dogs with hyperadrenocorticism, this suppression is impaired, leading to persistent cortisol production despite dexamethasone administration. Veterinarians use the LDDST primarily to confirm a diagnosis of hyperadrenocorticism and to differentiate between pituitary-dependent hyperadrenocorticism (PDH) and adrenal-dependent hypercorticism (ADH). The test provides valuable information about the functional status of the adrenal glands and the regulatory mechanisms that control cortisol secretion. The Merck Veterinary Manual provides authoritative background on endocrine disorders and diagnostic approaches in companion animals, which supports the clinical relevance of this testing protocol. The test is performed in a clinical setting and requires careful attention to timing, dosing, and sample handling to produce reliable results. ## Clinical Indications for the LDDST The LDDST is indicated when a dog presents with clinical signs consistent with hypercorticism. Common clinical signs include polyuria, polydipsia, polyphagia, abdominal distension, bilateral symmetric alopecia, muscle weakness, and panting. These signs are not specific to hypercorticism, so diagnostic testing is required to confirm the condition. Veterinarians typically consider the LDDST when baseline cortisol measurements are inconclusive or when the clinical picture strongly suggests hypercorticism. The test is also useful when the ACTH stimulation test results are equivocal or when there is a need to differentiate between PDH and ADH. The American Animal Hospital Association provides practice guidance for companion-animal care, which emphasizes the importance of systematic diagnostic approaches in endocrine disease. The LDDST is one component of a comprehensive diagnostic workup that includes physical examination, routine laboratory testing, and imaging studies. ## Physiology of the HPA Axis and Dexamethasone Suppression The hypothalamic-pituitary-adrenal axis regulates cortisol production through a cascade of hormonal signals. The hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates the anterior pituitary to release adrenocorticotropic hormone (ACTH). ACTH then acts on the adrenal cortex to stimulate cortisol synthesis and release. Cortisol exerts negative feedback on both the hypothalamus and the pituitary gland, reducing CRH and ACTH production when cortisol levels are elevated. Dexamethasone mimics cortisol in this feedback system, binding to glucocorticoid receptors in the pituitary and hypothalamus to suppress ACTH secretion. In healthy dogs, a low dose of dexamethasone suppresses cortisol production for a period of time. In dogs with hypercorticosteroid, this suppression is impaired. The degree of suppression depends on the underlying cause of the disease. In PDH, the pituitary tumor produces ACTH autonomously, but it may still retain some responsiveness to dexamethasone. In ADH, the adrenal tumor produces cortisol independently of ACTH, so dexamethasone has no effect on cortisol production. The World Small Animal Veterinary Association provides global clinical guidelines that support the use of standardized diagnostic protocols in companion-animal practice. Understanding the HPA axis physiology is essential for interpreting LDDST results correctly. ## Test Protocol and Sample Collection The LDDST requires a specific protocol to produce valid results. The veterinarian collects a baseline blood sample for cortisol measurement. Then, the dog receives an intravenous injection of dexamethasone at a low dose. The standard dose is 0.01 mg/kg, although some protocols use 0.015 mg/kg. The veterinarian collects additional blood samples at 4 hours and 8 hours after the dexamethasone injection. The timing of sample collection is critical. The 4-hour sample evaluates the early suppression response, and the 8-hour sample evaluates the duration of suppression. In healthy dogs, cortisol levels should be suppressed below the reference range at both time points. In dogs with hypercorticosteroid, cortisol levels remain elevated. Sample handling is also important. Blood samples should be collected into appropriate tubes, typically serum separator tubes or plain tubes without anticoagulant. The samples should be centrifuged and the serum separated promptly. The serum should be stored refrigerated or frozen if the assay is not performed immediately. The Cornell University College of Veterinary Medicine provides educational resources on diagnostic testing and sample handling in veterinary practice. Proper sample collection and handling are essential for accurate cortisol measurements. ## Interpretation of LDDST Results The interpretation of LDDST results depends on the cortisol concentrations at each time point. The baseline cortisol concentration is measured before dexamethasone administration. The 4-hour and 8-hour cortisol concentrations are measured after dexamethasone. In healthy dogs, the 4-hour and 8-hour cortisol concentrations should be suppressed to less than 50 percent of the baseline concentration. Some protocols use a specific cutoff value, such as less than 1.5 micrograms per deciliter, but the percentage suppression is the most commonly used criterion. In dogs with hypercorticosteroid, the cortisol concentrations remain elevated. The pattern of suppression can help differentiate PDH from ADH. In PDH, the 4-hour cortisol concentration may be suppressed, but the 8-hour cortisol concentration may escape from suppression. This escape phenomenon is called the escape pattern and is characteristic of PDH. In ADH, the cortisol concentrations remain elevated at both time points, with no suppression. The Merck Veterinary Manual provides detailed information on the interpretation of endocrine tests in dogs, including the LDDST. The manual emphasizes that the LDDST has a high sensitivity for diagnosing hypercorticosteroid but that the specificity is lower, meaning that false positives can occur. ## Differentiating PDH from ADH The LDDST is particularly useful for differentiating PDH from ADH. This differentiation is important because the treatment approach differs for each condition. PDH is typically treated with medical therapy, such as trilostane or mitotane, while ADH is treated with surgical removal of the adrenal tumor. The LDDST can differentiate PDH from ADH in approximately 60 to 75 percent of cases. In PDH, the 4-hour cortisol concentration is often suppressed to less than 50 percent of the baseline, but the 8-hour cortisol concentration may escape from suppression. In ADH, the cortisol concentrations remain elevated at both time points. The World Organisation for Animal Health provides official guidance on animal health and welfare, which includes the importance of accurate diagnosis for appropriate treatment. The differentiation between PDH and ADH is critical for selecting the appropriate treatment approach. ## At a Glance: LDDST Interpretation Table | Time Point | Healthy Dog | PDH (Pituitary-Dependent) | ADH (Adrenal-Dependent) | |------------|-------------|---------------------------|-------------------------| | Baseline cortisol | Normal or slightly elevated | Elevated | Elevated | | 4-hour post-dexamethasone | Suppressed below 50% of baseline | Suppressed below 50% of baseline | Not suppressed | | 8-hour post-dexamethasone | Suppressed below 50% of baseline | Escape from suppression (cortisol rises above 50% of baseline) | Not suppressed | This table summarizes the typical LDDST results for healthy dogs and dogs with PDH or ADH. The interpretation of these patterns requires clinical judgment and consideration of the patient's overall condition. ## Factors Affecting LDDST Results Several factors can affect the LDDST results and lead to false positives or false negatives. These factors include stress, concurrent illness, and medication use. Stress is a significant factor. Stressful events, such as hospitalization, blood collection, or other procedures, can activate the HPA axis and increase cortisol production. This stress-induced cortisol production can interfere with the suppression response and lead to a false positive result. Concurrent illness can also affect the LDDST. Dogs with chronic illness, such as diabetes mellitus, chronic kidney disease, or inflammatory conditions, may have elevated cortisol levels that are not suppressed by dexamethasone. This can lead to a false positive result. Medications can also interfere with the LDDST. Glucocorticoids, including topical or ophthalmic preparations, can suppress the HPA axis and lead to false negative results. Other medications, such as phenobarbital, can affect cortisol metabolism and alter the test results. The American Veterinary Medical Association provides pet-owner education resources that emphasize the importance of informing the veterinarian about all medications and health conditions before diagnostic testing. This information is essential for accurate test interpretation. ## False Positive Results False positive LDDST results occur when the test indicates hypercorticosteroid in a dog that does not have the disease. The most common cause of a false positive is stress-induced cortisol production. Stress can be caused by the test procedure itself, such as the stress of blood collection or the stress of being in a veterinary clinic. Other causes of false positive results include concurrent illness, such as chronic inflammation or infection, and certain medications. The veterinarian should consider these factors when interpreting the test results. If the LDDST is positive but the clinical signs are not consistent with hypercorticosteroid, the veterinarian may recommend repeating the test or performing additional tests, such as the ACTH stimulation test or abdominal ultrasound. ## False Negative Results False negative LDDST results occur when the test indicates normal cortisol suppression in a dog that actually has hypercorticosteroid. This can occur if the dog has a mild form of the disease or if the dexamethasone dose is too high. The use of exogenous glucocorticoids can also cause a false negative result. If the dog has been treated with glucocorticoids, the HPA axis may be suppressed, and the LDDST may not detect the underlying hypercorticosteroid. The veterinarian should consider the possibility of a false negative result if the clinical signs are strongly suggestive of hypercorticosteroid but the LDDST is normal. In this case, additional testing may be necessary. ## Protocol Deviations and Their Impact Protocol deviations can significantly affect the LDDST results. The most common deviations include incorrect dexamethasone dose, incorrect timing of sample collection, and improper sample handling. The dexamethasone dose must be accurate. An overdose of dexamethasone can cause suppression in a dog with hypercorticosteroid, leading to a false negative result. An underdose can fail to suppress cortisol in a healthy dog, leading to a false positive result. The timing of sample collection is also critical. The 4-hour and 8-hour samples must be collected at the correct times. If the samples are collected too early or too late, the results may be misinterpreted. Sample handling is also important. The blood samples must be processed promptly, and the serum must be separated from the cells. If the samples are not handled properly, the cortisol concentration may be affected, leading to inaccurate results. ## Practical Implementation Steps The following steps outline the practical implementation of the LDDST in a clinical setting: 1. Confirm the clinical suspicion of hypercorticosteroid based on history and physical examination. 2. Review the patient's medication list and discontinue any glucocorticoid therapy if possible. 3. Collect a baseline blood sample for cortisol measurement. 4. Administer dexamethasone at the appropriate dose intravenously. 5. Record the exact time of dexamethasone administration. 6. Collect blood samples at 4 hours and 8 hours after the dexamethasone injection. 7. Process the samples promptly and submit them to the laboratory for cortisol measurement. 8. Interpret the results in the context of the patient's clinical signs and other diagnostic findings. The World Small Animal Veterinary Association provides global guidelines for companion-animal care that emphasize the importance of standardized diagnostic protocols. Following a standardized protocol is essential for obtaining reliable LDDST results. ## Records and Measurements Accurate records are essential for the LDDST. The veterinarian should record the following information: - Patient identification and signalment - Clinical signs and duration - Current medications and dosages - Baseline cortisol concentration - Dexamethasone dose and route of administration - Time of dexamethasone administration - Time of each blood sample collection - Cortisol concentration at each time point - Any adverse events during the test These records are important for interpreting the results and for monitoring the patient's response to treatment. The records should be kept in the patient's medical file. ## Common Failure Patterns Several common failure patterns can occur when performing the LDDST. These include: - Incorrect dexamethasone dose - Incorrect timing of sample collection - Improper sample handling - Failure to consider stress or concurrent illness - Failure to discontinue interfering medications - Misinterpretation of borderline results These failure patterns can lead to inaccurate results and misdiagnosis. The veterinarian should be aware of these potential problems and take steps to avoid them. ## Limitations of the LDDST The LDDST has several limitations. The test is not 100% accurate, and false positives and false negatives can occur. The test is also time-consuming, requiring multiple blood samples over an 8-hour period. The LDDST cannot differentiate between PDH and ADH in all cases. In some cases, the test results are equivocal, and additional testing is needed. The LDDST is also affected by stress and concurrent illness, which can make the results difficult to interpret. The veterinarian should consider these limitations when using the LDDST to diagnose hypercorticosteroid. ## Safety and Welfare Considerations The LDDST is a relatively safe procedure, but there are some safety and welfare considerations. The test requires multiple blood collections, which can be stressful for the dog. The veterinarian should minimize stress by using gentle handling and providing a calm environment. The dexamethasone injection is generally well tolerated, but some dogs may experience adverse effects, such as vomiting or diarrhea. The veterinarian should monitor the dog for any adverse reactions during the test. The World Organisation for Animal Health provides guidance on animal health and welfare, which emphasizes the importance of minimizing stress and pain during diagnostic procedures. The veterinarian should follow these principles when performing the LDDST. ## Professional Escalation Criteria The veterinarian should escalate the case to a specialist in certain situations. These include: - If the LDDST results are ambiguous or equivocal - If the dog has concurrent illness that complicates the diagnosis - If the dog does not respond to treatment - If the dog has a suspected adrenal tumor that requires surgical removal The specialist may recommend additional tests, such as an ACTH stimulation test, abdominal ultrasound, or advanced imaging, to confirm the diagnosis and guide treatment. ## Alternative Diagnostic Tests The LDDST is one of several tests used to diagnose hypercorticosteroid. Other tests include the ACTH stimulation test, the urine cortisol-to-creatinine ratio, and abdominal ultrasound. The ACTH stimulation test measures the adrenal gland's response to synthetic ACTH. This test is used to diagnose hypercorticosteroid and to monitor treatment. The urine cortisol-to-creatinine ratio is a screening test that can be used to rule out hypercorticosteroid. Abdominal ultrasound can be used to visualize the adrenal glands and to detect adrenal tumors. The choice of test depends on the clinical situation and the veterinarian's preference. The LDDST is often used as a first-line test because it can differentiate PDH from ADH. ## The Role of Imaging in Diagnosis Imaging studies, such as abdominal ultrasound, can be used to evaluate the adrenal glands. In PDH, the adrenal glands may be symmetrically enlarged. In ADH, one adrenal gland may be enlarged, and the other may be atrophied. Imaging can also be used to detect adrenal tumors. If an adrenal tumor is detected, the veterinarian may recommend surgical removal. The Merck Veterinary Manual provides information on the use of imaging in the diagnosis of endocrine disorders in dogs. Imaging is a valuable tool for confirming the diagnosis and for guiding the treatment. ## The Role of the ACTH Stimulation Test The ACTH stimulation test is another diagnostic test used to evaluate the HPA axis. This test measures the adrenal gland's response to synthetic ACTH. The test is performed by collecting a baseline cortisol sample, administering synthetic ACTH, and collecting a post-ACTH cortisol sample. The ACTH stimulation test is used to diagnose hypercorticosteroid and to differentiate PDH from ADH. The test is also used to monitor the response to treatment. The LDDST and the ACTH stimulation test are complementary tests. The LDDST is more sensitive for diagnosing hypercorticosteroid, while the ACTH stimulation test is more specific for differentiating PDH from ADH. ## The Urine Cortisol-to-Creatinine Ratio The urine cortisol-to-creatinine ratio is a screening test for hypercorticosteroid. The test measures the amount of cortisol in the urine relative to the amount of creatinine. The test is easy to perform and can be done at home. The urine cortisol-to-creatinine ratio has a high sensitivity for hypercorticosteroid, but it has a low specificity. This means that a normal result can rule out the disease, but an elevated result does not confirm the disease. The test is often used as a screening test before performing the LDDST or the ACTH stimulation test. If the urine cortisol-to-creatinine ratio is normal, the LDDST may not be necessary. ## The Role of Abdominal Ultrasound Abdominal ultrasound is a useful imaging technique for evaluating the adrenal glands. The ultrasound can detect adrenal gland enlargement, adrenal tumors, and other abnormalities. In PDH, the adrenal glands may be symmetrically enlarged. In ADH, one adrenal gland may be enlarged, and the other may be atrophied. The ultrasound can also detect adrenal tumors, which may be benign or malignant. The ultrasound is a non-invasive procedure that can be performed in the clinic. The ultrasound can help differentiate PDH from ADH and can guide the treatment. ## The Role of the Veterinarian The veterinarian plays a central role in the diagnosis and management of hypercorticosteroid. The veterinarian is responsible for performing the LDDST, interpreting the results, and recommending the appropriate treatment. The veterinarian should also provide the pet owner with information about the disease and the treatment options. The American Veterinary Medical Association provides pet-owner education resources that can help pet owners understand the disease and the treatment. The veterinarian should also monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with guidance on the long-term management of the disease. ## The Role of the Pet Owner The pet owner plays an important role in the diagnosis and management of hypercorticosteroid. The pet owner should provide the veterinarian with a complete history of the pet's health, including any medications the pet is taking. The pet owner should also follow the veterinarian's instructions for the LDDST, including the collection of blood samples and the administration of dexamethasone. The pet owner should also monitor the pet for any adverse reactions during the test. The pet owner should also be aware of the signs of hypercorticosteroid and should report any changes to the veterinarian. The pet owner should also follow the veterinarian's instructions for the treatment and management of the disease. ## The Importance of Early Diagnosis Early diagnosis of hypercorticosteroid is important for the successful treatment of the disease. The LDDST is a valuable tool for the early diagnosis of the disease. Early diagnosis can help prevent the complications of the disease, such as diabetes, hypertension, and infections. Early diagnosis can also improve the prognosis for the patient. The LDDST is a reliable test for the diagnosis of hypercorticosteroid. The test is also useful for the differentiation of PDH from ADH. ## The Importance of Accurate Diagnosis Accurate diagnosis is important for the successful treatment of hypercorticosteroid. The LDDST is a valuable tool for the accurate diagnosis of the disease. The LDDST can help differentiate PDH from ADH, which is important for the selection of the appropriate treatment. The LDDST can also help to rule out other diseases that may cause similar signs. The LDDST is a reliable test for the diagnosis of hypercorticosteroid. The test is also useful for the diagnosis of the disease. ## The Importance of the LDDST in Veterinary Medicine The LDDST is an important diagnostic tool in veterinary medicine. The test is used to diagnose hypercorticosteroid and to differentiate PDH from ADH. The LDDST is a reliable test that is used in clinical practice. The test is also used in research to study the HPA axis. The LDDST is a valuable tool for the diagnosis and management of hypercorticosteroid. The test is also a useful tool for the diagnosis of other endocrine disorders. ## The Future of the LDDST The LDDST is a well-established diagnostic test that is used in veterinary medicine. The test is likely to continue to be used in the future. The LDDST may be improved in the future with the development of new assays and new protocols. The test may also be used in combination with other tests to improve the accuracy of the diagnosis. The LDDST is a valuable tool for the diagnosis and management of hypercorticosteroid. The test is likely to continue to be used in the future. ## A Structured Decision Framework for Equivocal LDDST Results Veterinarians frequently encounter LDDST results that fall into a gray zone, where cortisol concentrations neither clearly confirm nor exclude hyperadrenocorticism. A structured decision framework helps clinicians move from pattern recognition to a defensible diagnostic plan when results are equivocal. This framework organizes the interpretation process into sequential checkpoints that account for test limitations, patient factors, and the clinical picture. ### Defining the Equivocal Result Zone An equivocal LDDST result is one where the cortisol suppression pattern does not match the classic profiles for healthy dogs, pituitary-dependent hyperadrenocorticism, or adrenal-dependent hypercortisolism. Common equivocal patterns include a 4-hour cortisol that is suppressed but an 8-hour cortisol that is only partially suppressed, or a baseline cortisol that is elevated with minimal suppression at both time points but not to the degree expected in confirmed disease. The Merck Veterinary Manual notes that endocrine test interpretation requires consideration of the entire clinical picture instead of isolated laboratory values. A structured framework begins by defining what constitutes an equivocal result in your practice. Establish clear criteria before the test is performed. For example, an equivocal result may be defined as a 4-hour cortisol between 50 and 60 percent of baseline, or an 8-hour cortisol that falls between 40 and 50 percent of baseline. These thresholds should be written into the practice protocol so that all clinicians apply the same standard. ### Checkpoint One: Verify Protocol Fidelity The first step in the decision framework is to verify that the test was performed exactly as specified. Protocol deviations are a common cause of equivocal results. The veterinarian should review the medical record to confirm the dexamethasone dose, the route of administration, and the exact timing of each blood collection. The dexamethasone dose must be calculated based on the dog's current body weight. A dose that is too low may fail to suppress cortisol in a healthy dog, while a dose that is too high may suppress cortisol in a dog with mild hypercortisolism. The timing of the 4-hour and 8-hour samples is equally critical. A sample collected at 3.5 hours or 8.5 hours can produce results that fall outside the expected ranges. Sample handling errors can also produce equivocal results. Serum must be separated from the clot within a reasonable time frame, and the samples must be stored properly before analysis. If the samples were hemolyzed or lipemic, the cortisol assay may be affected. The veterinarian should contact the laboratory to confirm that the samples were received in good condition and that the assay was performed without technical issues. ### Check Two: Assess Stress and Concurrent Illness If the protocol was followed correctly, the next step is to assess the patient for factors that can affect cortisol dynamics. Stress is a well-documented cause of false positive LDDST results. The stress of hospitalization, blood collection, or other procedures can activate the HPA axis and interfere with the suppression response. The veterinarian should review the patient's history for any stressful events in the 24 hours before the test. This includes travel to the clinic, boarding, or changes in the home environment. If the dog was stressed during the test, the results may not be reliable. Concurrent illness is another important consideration. Dogs with chronic inflammation, infection, or other endocrine disorders may have elevated cortisol levels that do not suppress normally. The veterinarian should review the patient's medical history and current medications to identify any conditions that could affect the test. The American Animal Hospital Association provides practice guidance that emphasizes the importance of considering the whole patient when interpreting diagnostic tests. A structured framework should include a checklist of common stressors and concurrent illnesses that can affect the LDDST. ### Check Three: Evaluate Medication Interference Medications can interfere with the LDDST in several ways. Exogenous glucocorticoids, including topical, ophthalmic, or oral preparations, can suppress the HPA axis and lead to false negative results. The veterinarian should review the patient's complete medication list, including any over-the-counter or prescription products. Other medications may affect cortisol metabolism or the assay itself. Phenobarbital and other hepatic enzyme inducers can alter cortisol clearance, potentially affecting the test results. The veterinarian should consider whether any current medications could explain an equivocal result. If a medication is identified as a potential interfering factor, the veterinarian should decide whether to repeat the test after discontinuing the medication or to proceed with alternative diagnostic testing. The decision should be based on the clinical urgency and the potential risks of discontinuing the medication. ### Check Four: Compare with the Clinical Picture The next step is to compare the LDDST results with the patient's clinical signs and other diagnostic findings. The LDDST should not be interpreted in isolation. The veterinarian should consider the history, physical examination findings, and routine laboratory results. If the clinical signs are strongly suggestive of hypercorticosteroid, an equivocal LDDST result may be sufficient to proceed with treatment. If the clinical signs are mild or nonspecific, the veterinarian may recommend additional testing before making a diagnosis. The World Small Animal Veterinary Association provides global clinical guidelines that support the use of a comprehensive diagnostic approach in companion-animal practice. The clinical picture should be the primary driver of the diagnostic plan, with the LDDST serving as one piece of evidence. ### Check Five: Determine the Need for Additional Testing If the LDDST result is equivocal and the clinical picture is unclear, the veterinarian should consider additional testing. The ACTH stimulation test is a complementary test that can provide additional information about the HPA axis. Abdominal ultrasound can be used to evaluate the adrenal glands for enlargement or tumors. The choice of additional testing depends on the specific clinical situation. If the LDDST suggests PDH but the clinical signs are atypical, an abdominal ultrasound may be helpful to confirm the diagnosis. If the LDDST is equivocal and the patient has a concurrent illness, the ACTH stimulation test may be more reliable. The veterinarian should discuss the options with the pet owner and explain the rationale for additional testing. The American Veterinary Medical Association provides pet-owner education resources that can help owners understand the diagnostic process. ### Check Six: Document the Decision and Plan The final step in the framework is to document the decision and the plan. The medical record should include the LDDST results, the factors considered, and the rationale for the decision. This documentation is important for continuity of care and for monitoring the patient's response to treatment. The record should also include a plan for follow-up. If the decision is to proceed with treatment, the veterinarian should schedule a recheck to assess the response. If the decision is to repeat the test or perform additional testing, the veterinarian should schedule the appropriate procedures. The World Organisation for Animal Health provides official guidance on animal health and welfare, which emphasizes the importance of accurate diagnosis for appropriate treatment. A structured decision framework supports this goal by ensuring that equivocal results are handled systematically. ### A Practical Decision Tree for Equivocal Results The following decision tree can be used in clinical practice when an LDDST result is equivocal: 1. Verify the protocol was followed correctly. If not, repeat the test with correct protocol. 2. Assess the patient for stress and concurrent illness. If present, consider repeating the test under less stressful conditions or treating the underlying illness first. 3. Review the medication list for interfering drugs. If a medication is identified, discuss with the owner whether it can be discontinued. 4. Compare the LDDST result with the clinical picture. If the clinical signs are strong, proceed with treatment. If the signs are mild, consider additional testing. 5. Choose the next diagnostic step based on the patient's situation. Options include the ACTH stimulation test, abdominal ultrasound, or a urine cortisol-to-creatinine ratio. 6. Document the decision and the plan in the medical record. This decision tree provides a clear path for handling equivocal results and reduces the risk of misdiagnosis. ### Common Failure Patterns in the Decision Framework Several common failure patterns can undermine the decision framework. The most common is skipping the protocol verification step. If the protocol was not followed correctly, the result is not reliable, and the remaining steps are meaningless. Another failure pattern is ignoring the clinical picture. The LDDST is a diagnostic tool, not a substitute for clinical judgment. If the clinical signs are strongly suggestive of hypercorticosterism, an equivocal LDDST result should not prevent treatment. A third failure pattern is failing to document the decision. Without documentation, the rationale for the decision is lost, and the patient's care may be compromised. ### The Role of the Specialist in Equivocal Cases In some cases, the veterinarian may need to escalate the case to a specialist. This is appropriate when the LDDST result is equivocal and the clinical picture is complex, or when the patient has a concurrent illness that complicates the diagnosis. A specialist may have access to advanced diagnostic tools, such as endogenous ACTH concentration measurement or advanced imaging. The specialist can also provide a second opinion on the interpretation of the LDDST results. The decision to escalate should be based on the patient's needs and the veterinarian's comfort level. The veterinarian should not hesitate to seek specialist input when the diagnosis is unclear. ### The Value of a Structured Approach A structured decision framework for equivocal LDDST results provides several benefits. It ensures that the veterinarian considers all relevant factors before making a decision. It reduces the risk of misdiagnosis and inappropriate treatment. It also provides a clear record of the decision-making process, which is important for the medical record and for the pet owner. The framework is not a substitute for clinical judgment. The veterinarian should use the framework as a guide and adapt it to the specific situation. The framework is a tool to support the veterinarian in making the best decision for the patient. ### The Role of the Pet Owner in the Decision Process The pet owner plays an important role in the decision process. The veterinarian should explain the LDDST results and the decision framework to the owner. The owner should understand the reasons for the decision and the next steps. The owner should also be informed about the limitations of the LDDST and the possibility of equivocal results. This helps the owner understand the diagnostic process and the need for additional testing. The American Veterinary Medical Association provides pet-owner education resources that can help owners understand the diagnostic process and the importance of following the veterinarian's recommendations. ### The Importance of a Standardized Approach A standardized approach to the LDDST is essential for reliable results. The veterinarian should follow the same protocol for every patient, including the same dexamethasone dose, the same timing of sample collection, and the same sample handling procedures. The World Small Animal Veterinary Association provides global guidelines that support the use of standardized diagnostic protocols. A standardized approach reduces the risk of protocol deviations and improves the reliability of the test. The veterinarian should also document the protocol in the medical record so that the test can be repeated in the same way if needed. This is important for monitoring the patient's response to treatment. ### The Role of the Laboratory The laboratory plays an important role in the LDDST. The laboratory should provide accurate and reliable cortisol measurements. The laboratory should also provide reference ranges for the cortisol assay. The veterinarian should communicate with the laboratory if there are any questions about the results. The laboratory can provide information about the assay and the sample handling requirements. The Cornell University College of Veterinary Medicine provides educational resources on diagnostic testing and sample handling. The veterinarian should follow the laboratory's recommendations for sample collection and handling. ### The Importance of the Clinical Context The LDDST should always be interpreted in the context of the clinical picture. The test is a diagnostic tool, not a substitute for clinical judgment. The veterinarian should consider the patient's history, physical examination findings, and other diagnostic results when interpreting the LDDST. The clinical context is particularly important when the LDDST result is equivocal. The veterinarian should use the decision framework to determine the next steps, but the final decision should be based on the patient's needs. ### The Value of the Decision Framework The decision framework provides a structured way to handle equivocal LDDST results. It ensures that the veterinarian considers all the factors before making a decision. It reduces the risk of misinterpretation and misdiagnosis. It also provides a clear record of the decision-making process. The framework is not a substitute for clinical judgment. The veterinarian should use the framework as a guide and adapt it to the clinical situation. The framework is a tool for the veterinarian, not a replacement for the veterinarian. ### The Next Steps The next steps after an equivocal LDDST result depend on the clinical situation. The veterinarian should use the decision framework to determine the next step. The next step may be to repeat the test, perform additional testing, or proceed with treatment. The veterinarian should discuss the next steps with the pet owner and explain the reasons for the decision. The owner should be informed about the limitations of the LDDST and the need for additional testing. The veterinarian should also document the decision and the plan in the medical record. This is important for the continuity of care and for monitoring the patient's response to treatment. ### The Importance of Follow-Up Follow-up is important after an equivocal LDDST result. The veterinarian should schedule a recheck to assess the patient's condition and to determine whether the diagnosis has changed. The follow-up may include repeat testing or additional diagnostic procedures. The follow-up should also include a discussion with the pet owner about the patient's progress and any changes in the clinical signs. The owner should be encouraged to report any changes to the veterinarian. The follow-up is important for the long-term management of the patient. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. ### The Role of the Specialist The specialist can provide additional expertise in the management of equivocal LDDST results. The specialist may recommend additional testing or advanced imaging. The specialist may also provide a second opinion on the diagnosis and the treatment plan. The veterinarian should not hesitate to refer the patient to a specialist when the diagnosis is uncertain. The specialist can provide the expertise needed to make the best decision for the patient. ### The Final Decision The final decision about the management of an equivocal LDDST result should be based on the clinical picture and the patient's needs. The veterinarian should use the decision framework to guide the decision, but the final decision should be made in the best interest of the patient. The veterinarian should also consider the pet owner's preferences and the owner's ability to manage the treatment. The veterinarian should discuss the options with the owner and make a decision that is appropriate for the patient and the owner. ### The Importance of the Decision The decision about the management of an equivocal LDDST result is important because it affects the patient's care. The decision should be based on the best available evidence and the clinical judgment of the veterinarian. The decision framework provides a structured way to make the decision. The framework ensures that the veterinarian considers all the factors and makes a decision that is in the best interest of the patient. ### The Role of the Veterinarian The veterinarian plays a central role in the management of equivocal LDDST results. The veterinarian is responsible for the interpretation of the results and the decision-making process. The veterinarian should also provide the pet owner with the information needed to make an informed decision. The veterinarian should also monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with guidance on the long-term management of the patient. ### The Role of the Pet Owner The pet owner plays an important role in the management of equivocal LDDST results. The owner should provide the veterinarian with a complete history of the patient's health and any medications the patient is taking. The owner should also follow the veterinarian's instructions for the test and the treatment. The owner should also be aware of the signs of hypercorticosterism and should report any changes to the veterinarian. The owner should also follow the veterinarian's instructions for the long-term management of the patient. ### The Importance of the Decision Framework The decision framework is an important tool for the management of equivocal LDDST results. The framework provides a structured way to handle the results and to make a decision. The framework also provides a record of the decision-making process. The framework is not a substitute for clinical judgment. The veterinarian should use the framework to guide the decision and adapt it to the clinical situation. The framework is a tool for the veterinarian, not a replacement for the veterinarian. ### The Final Decision The final decision about the management of an equivocal LDDST result should be made by the veterinarian in consultation with the pet owner. The decision should be based on the clinical picture, the patient's needs, and the owner's preferences. The decision should be documented in the medical record and communicated to the pet owner. The decision should also be reviewed at the follow-up visit to ensure that it is appropriate for the patient. ### The Importance of the Clinical Context The clinical context is the most important factor in the management of an equivocal LDDST result. The veterinarian should consider the patient's history, physical examination findings, and other diagnostic results when making the decision. The clinical context should also be considered when interpreting the LDDST results. The LDDST is a diagnostic tool, not a substitute for clinical judgment. The veterinarian should use the clinical context to guide the interpretation of the results. ### The Final Recommendation The final recommendation for the management of an equivocal LDDST result is to use a structured decision framework. The framework should include the steps outlined above, and the veterinarian should use the framework to guide the decision. The veterinarian should also consider the clinical context and the patient's needs when making the decision. The decision should be documented in the medical record and communicated to the pet owner. ### The Final Decision The final decision about the management of an equivocal LDDST result should be made by the veterinarian in consultation with the pet owner. The decision should be based on the clinical picture, the patient's needs, and the owner's concerns. The decision should be documented in the medical record and communicated to the pet owner. The decision should also be reviewed at the follow-up to ensure that it is appropriate for the patient. ### The Final Step The final step in the management of an equivocal LDDST result is to implement the decision and monitor the patient's response. The veterinarian should follow up with the patient to assess the response to treatment and to adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the patient's condition. The owner should be informed about the patient's condition and the treatment plan. ### The Final Outcome The final outcome of the management of an equivocal LDDST result depends on the patient's condition and the treatment plan. The veterinarian should monitor the patient's response to treatment and adjust the treatment as needed. The veterinarian should also provide the pet owner with the information needed to manage the ## Frequently Asked Questions ### What is the low-dose dexamethasone suppression test? The low-dose dexamethasone suppression test is a diagnostic procedure used to evaluate the function of the adrenal glands in dogs. It measures the ability of the pituitary gland to suppress cortisol production in response to a low dose of dexamethasone. ### How is the LDDST performed? The LDDST is performed by collecting a baseline blood sample, administering a low dose of dexamethasone intravenously, and collecting additional blood samples at 4 and 8 hours after the injection. The cortisol concentrations are measured in each sample. ### What do the LDDST results mean? The LDDST results can indicate whether a dog has hypercorticosteroid and whether the disease is pituitary-dependent or adrenal-dependent. The results are interpreted based on the cortisol concentrations at each time point. ### What are the limitations of the LDDST? The LDDST has limitations, including the possibility of false positives and false negatives. The test is also affected by stress and concurrent illness, which can make the results difficult to interpret. ### What is the difference between the LDDST and the ACTH stimulation test? The LDDST and the ACTH stimulation test are both used to diagnose hypercorticosteroid. The LDDST is more sensitive for diagnosing the disease, while the ACTH stimulation test is more specific for differentiating PDH from ADH. ### What should I do if my dog has a positive LDDST result? If your dog has a positive LDDST result, you should discuss the results with your veterinarian. The veterinarian may recommend additional tests, such as an abdominal ultrasound, to confirm the diagnosis and guide the treatment. ### What is the treatment for hypercorticosteroid? The treatment for hypercorticosteroid depends on the underlying cause. PDH is typically treated with medical therapy, while ADH is treated with surgical removal of the adrenal tumor. The veterinarian will recommend the appropriate treatment. ### How can I prevent false LDDST results? You can help prevent false LDDST results by providing the veterinarian with a complete history of your pet's health, including any medications the pet is taking. You should also follow the veterinarian's instructions for the test. ## Using the Evidence | Source | Best use in this topic | Important limitation | |---|---|---| | [Pet Care](https://www.avma.org/resources-tools/pet-owners) | official guidance | Check the linked page for current local requirements | | [AAHA Guidelines](https://www.aaha.org/resources) | official guidance | Check the linked page for current local requirements | | [Global Guidelines](https://wsava.org/global-guidelines) | official guidance | Check the linked page for current local requirements | ## Related Veterinary Guides - [Interpreting Diagnostic Test Results in NAVLE Scenarios](/knowledge/veterinary-medicine/navle-exam-prep/interpreting-diagnostic-test-results-in-navle-scenarios) - [NPH Insulin Dogs Dose: Canine Diabetes Twice Daily Protocol](/knowledge/veterinary-medicine/calculators-clinical-tools/nph-insulin-dogs-dose-canine-diabetes-twice-daily-protocol) - [Interpreting Endocrine Assay Results in Small Animals](/knowledge/veterinary-medicine/clinical-internal-medicine/interpreting-endocrine-assay-results-small-animals) - [Why Is My Dog face swelling after bee sting? Anaphylaxis Emergency Protocol](/knowledge/veterinary-medicine/symptom-guides/why-is-my-dog-face-swelling-after-bee-sting-anaphylaxis-emergency-protocol) - [Canine DNA & Sensitivity Test Kits: Genetic Health Screening, Variant Accuracy, and Panel Limitations](/knowledge/veterinary-medicine/at-home-diagnostics/dog-dna-allergy-test-kit) ## References and Further Reading - [Pet Care](https://www.avma.org/resources-tools/pet-owners). American Veterinary Medical Association. - [AAHA Guidelines](https://www.aaha.org/resources). American Animal Hospital Association. - [Global Guidelines](https://wsava.org/global-guidelines). World Small Animal Veterinary Association. - [Merck Veterinary Manual](https://www.merckvetmanual.com/). Merck Veterinary Manual. - [Cornell University College of Veterinary Medicine](https://www.vet.cornell.edu/). Cornell University. - [Animal Health and Welfare](https://www.woah.org/en/what-we-do/animal-health-and-welfare). World Organisation for Animal Health. - [Patterns of the low-dose dexamethasone suppression test in canine hyperadrenocorticism revisited.](https://pubmed.ncbi.nlm.nih.gov/33728722). Veterinary clinical pathology, 2021. - [Re-evaluation of the low-dose dexamethasone suppression test in dogs.](https://pubmed.ncbi.nlm.nih.gov/36089334). The Journal of small animal practice, 2023. - [Frequency of low-dose dexamethasone suppression test (LDDST) response patterns and their correlation with clinicopathologic signs in dogs suspected of having Cushing's syndrome: A retrospective study.](https://pubmed.ncbi.nlm.nih.gov/38851053). Research in veterinary science, 2024. - [Extended low-dose dexamethasone suppression test for diagnosis of atypical Cushing's syndrome in dogs.](https://pubmed.ncbi.nlm.nih.gov/28371654). Domestic animal endocrinology, 2017. - [Evaluation of individual low-dose dexamethasone suppression test patterns in naturally occurring hyperadrenocorticism in dogs.](https://pubmed.ncbi.nlm.nih.gov/29498108). Journal of veterinary internal medicine, 2018. > This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.